Sign In
Buy CPRX
$31.49
+0 (+0%)
At Close: Jul 31, 2026
Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances
04:54am, Thursday, 18'th Jan 2024
The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a recession,
3 Biotech Stocks You Can Buy and Hold for the Next Decade
08:45am, Monday, 15'th Jan 2024
Catalyst buys appealing medicines or pharmaceutical assets and gets them out the door. Recursion uses AI and vast biomedical data to discover and exploit leads for new drugs.
5 Value Stocks With Strong Earnings Yield to Rev Up Returns
09:01am, Wednesday, 10'th Jan 2024
Consider investing in high-yield value stocks like GCT, SKYW, METC, EMN and CPRX to unlock your portfolio's potential.
New Strong Buy Stocks for January 10th
07:31am, Wednesday, 10'th Jan 2024
PCRFY, IMCR, CPRX, AMPX and ENS have been added to the Zacks Rank #1 (Strong Buy) List on January 10, 2024.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Wednesday, 03'rd Jan 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is Catalyst Pharmaceuticals (CPRX) Stock a Solid Choice Right Now?
09:46am, Tuesday, 02'nd Jan 2024
Catalyst Pharmaceuticals (CPRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
12:03pm, Sunday, 17'th Dec 2023
With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like advancements in the digital
Catalyst (CPRX) Q3 Earnings Miss, Sales Top, '23 View Up
09:49am, Thursday, 09'th Nov 2023
Catalyst (CPRX) reports mixed third-quarter results. Firdapse and Fycompa sales continue to boost revenues.
Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023
08:03am, Monday, 23'rd Oct 2023
The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET
3 Solid Stocks to Buy for Superb Earnings Acceleration
07:31am, Wednesday, 18'th Oct 2023
Invest in stocks such as Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN) and Inari Medical (NARI) for solid earnings acceleration.
Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse
02:17pm, Monday, 16'th Oct 2023
The FDA accepts Catalyst's (CPRX) sNDA to increase the indicated maximum daily dosage of Firdapse 10 mg from 80mg to 100mg for treating Lambert-Eaton myasthenic syndrome. The decision is due on Jun 4,
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
10:31am, Thursday, 12'th Oct 2023
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
New Strong Buy Stocks for October 11th
09:02am, Wednesday, 11'th Oct 2023
PBF, PRAX, CPRX, MFA and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2023.
4 Stocks That Exhibit Solid Earnings Acceleration
09:01am, Friday, 06'th Oct 2023
Invest in stocks like Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), Inari Medical (NARI) and Kyndryl Holdings (KD) for superb earnings acceleration.
Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
08:03am, Monday, 18'th Sep 2023
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
